The role of celecoxib in glioblastoma treatment: a review of literature
Objective: Glioblastoma (GB) is the most aggressive and lethal type of brain tumor. Despite the standard treatments and improvements, the overall survival (OS) and progression free survival (PFS) are not optimal. Celecoxib (CEL) has been considered as one of the adjuvant agents in patients with GB d...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2020-07-01
|
| Series: | World Cancer Research Journal |
| Subjects: | |
| Online Access: | https://www.wcrj.net/wp-content/uploads/sites/5/2020/11/e1617.pdf |